AllPress MentionsLesaffre strengthens its presence in the United StatesNovember 20, 2023Read moreSynthetic biology could disrupt some of the world’s biggest industries. Here are four steps to building a ‘syn-bio’ strategyMarch 3, 2023Read moreLesaffre acquires Recombia Biosciences, a biotechnology company specialized in high-throughput genome editing and synthetic biologySeptember 7, 2022Read moreLesaffre and Recombia Biosciences to Advance Innovative Gene Editing Technology Through a Strategic PartnershipOctober 30, 2020Read more
